Board
In our letter of 2 October 2026, we informed you of the candidates proposed by the incumbent Board of the GDCh Division Association for Chemistry and Economics for the upcoming Board election. No further nominations were submitted by members. Accordingly, the Board election will be held with the following candidates, all of whom have agreed to stand.
| Name | Affiliation | Election status |
| Dr. Kay Bernhard | Cerdia Services GmbH, Freiburg | New election |
| Dr. Adam Franz | CropEnergies AG & CropEnergies Biobased Chemicals GmbH, Mannheim | New election |
| Dr. Beate Glomb | Walter Rau Neusser Öl und Fett AG, Neuss | New election |
| Dr. Franziska Grün | BASF Agricultural Solutions, Limburgerhof | New election |
| Dr. André Hemmelder | Boston Consulting Group, Düsseldorf | New election |
| Dr. Achim Ilzhöfer | Covestro AG, Leverkusen | New election |
| Jana Kriesel | Shell Deutschland GmbH, Cologne | New election |
| Miriam Seebach | Swagelok Frankfurt | New election |
| Dr. Julian Vogel | Rentschler Biopharma SE, Laupheim | Re-election |
| Prof. Dr. Stephan von Delft | University of Münster | Re-election |
Under the Division's bylaws, the Board consists of a maximum of ten members
(1 Chair, 1 Deputy Chair, max. 8 ordinary members), each elected for a term of three years. One re-election is permitted.
All members with an email address on file will receive a personalised voting link on Monday, 9 November 2026. All other members will receive their voting documents by post.
The ballot envelopes will be opened and counted at the GDCh Office, Varrentrappstr. 40-42, 60486 Frankfurt am Main. The election results will be announced in Nachrichten aus der Chemie and on the Division's website.
Dr. Hervé Baratte is a self-employed, independent consultant at "Groth Strategy Innovation".
Innovation Networks: Adidas, Airbus, Air Liquide, BASF, BMW, Boehringer-Ingelheim, Bosch, Cr.Hansen, Evonik Industries, DHL, DSM, GE, Henkel, IBM, Johnson & Johnson, 3M, Merck, Novozymes, Philips, Sanofi, Shell, Siemens, Solvay, Sulzer ...
Innovation partnering: between “Elephants” & “Mouse” SMEs, Start-ups
Professional Career
1983: Thomson CSF Research, France
1985: IBM Research, USA
1990: IBM Manufacturing, Germany.
1993: Cap Gemini Vice President
2000: Accenture Associate Partner
2003: Independent Consultant
1995: Professor Innovation Strategy MBA www.cdi.fr
Author: 30 publications, scientific and business
Holger Bengs studied Chemistry in Hannover and Mainz as well as Business Administration in Hagen. He is the founder and managing partner of BCNP Consultants GmbH, based in Frankfurt, formerly Dr. Holger Bengs Biotech Consulting. Founded in 2002, the company has ten employees, predominantly natural scientists, and specialises in the four industry sectors biotech, chemistry, nanotech and pharmaceuticals (BCNP). Since 2011, the company has also had an office in Dresden (www.bcnp-consultants.com).
H. Bengs has been a member of the Association of Chemistry and Economics (VCW) for ten years and has been part of the core team for six years. His specialist area there is industrial biotechnology. This led to interdisciplinary lecture events in December 2005 in Frankfurt at Infraserv Höchst and in April 2008 in Leipzig at c-LEcta GmbH, which were very well received. Since May 2009, VCW round tables have regularly been held in Frankfurt and other cities on his initiative, providing opportunities for informal exchange.
Dr. rer. nat. Werner Breuers (born in 1958) completed his doctorate at RWTH Aachen University and began his professional career in 1989 as a chemist at Hoechst AG in Frankfurt. After holding various management positions, including President of Basell Polyolefins Europe, based in Hoofddorp near Amsterdam, he joined LANXESS. Since May 2007, he has been a member of the Management Board, responsible for Performance Polymers and Advanced Intermediates. “VCW is a vibrant example of the successful collaboration between the natural sciences and economics. I would like to contribute to this through my involvement.”